Evidence map›Paper›PMID 20233929›Full record

ArticleJournal of bacteriology2010

Phosphorylation of MgrA and its effect on expression of the NorA and NorB efflux pumps of Staphylococcus aureus.

Que Chi Truong-Bolduc, David C Hooper

Open access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 88 citations in OpenAlex.

  1. Genomic Characterization and Virulence Determinants ofAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Article
  3. A small regulatory RNA controls antibiotic adaptation inAntimicrobial agents and chemotherapy · 2025
    Article
  4. Article
  5. NosocomialInternational journal of molecular sciences · 2025
    Article
  6. Article
  7. Efflux pumps: gatekeepers of antibiotic resistance inMicrobial cell (Graz, Austria) · 2024
    Article
  8. Article
  9. Role ofJournal of bacteriology · 2022
    Article
  10. Review
  11. Flavonoids as Inhibitors of Bacterial Efflux Pumps.Molecules (Basel, Switzerland) · 2021
    Review
  12. Microorganisms · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Que Chi Truong-BolducDivision of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston MA 02114-2696, USA.
David C Hooper
Harvard University · USMassachusetts General Hospital · US

Funding

Quinolone and multidrug resistance in Staphylococcus aureusR37AI023988 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HOOPER, DAVID C · 2008 to 2017
$4.1M
NIAID NIH HHS R37 AI023988NIAID NIH HHS R37 AI23988
6 · The paper itself

Abstract

MgrA is a global regulator in Staphylococcus aureus that controls the expression of diverse genes encoding virulence factors and multidrug resistance (MDR) efflux transporters. We identified pknB, which encodes the (Ser/Thr) kinase PknB, in the S. aureus genome. PknB was able to autophosphorylate as well as phosphorylate purified MgrA. We demonstrated that rsbU, which encodes a Ser/Thr phosphatase and is involved in the activation of the SigB regulon, was able to dephosphorylate MgrA-P but not PknB-P. Serines 110 and 113 of MgrA were found to be phosphorylated, and Ala substitutions at these positions resulted in reductions in the level of phosphorylation of MgrA. DNA gel shift binding assays using norA and norB promoters showed that MgrA-P was able to bind the norB promoter but not the norA promoter, a pattern which was the reverse of that for unphosphorylated MgrA. The double mutant MgrA(S110A-S113A) bound to the norA promoter but not the norB promoter. The double mutant led to a 2-fold decrease in norA transcripts and a 2-fold decrease in the MICs of norfloxacin and ciprofloxacin in strain RN6390. Thus, phosphorylation of MgrA results in loss of binding to the norA promoter, but with a gain of the ability to bind the norB promoter. Loss of the ability to phosphorylate MgrA by Ala substitution resulted in increased repression of norA expression and in reductions in susceptibilities to NorA substrates.

Indexed as

ATP-Binding Cassette, Sub-Family C ProteinsBacterial ProteinsBase SequenceCiprofloxacinElectrophoretic Mobility Shift AssayGene Expression Regulation, BacterialMicrobial Sensitivity TestsMolecular Sequence DataMutagenesis, Site-DirectedNorfloxacinPhosphorylationPromoter Regions, GeneticProtein BindingReverse Transcriptase Polymerase Chain ReactionStaphylococcus aureusATP-Binding Cassette, Sub-Family C ProteinsBacterial ProteinsCiprofloxacinNorA protein, StaphylococcusNorfloxacin

Identifiers

PMID20233929
PMCPMC2863576
OpenAlexW2013381224

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.